Skip to Content

MAX REMEDIES THROAT LOZENGES

Active substance(s): CETYLPYRIDINIUM CHLORIDE

View full screen / Print PDF » Download PDF ⇩
Transcript
SUMMARY OF PRODUCT CHARACTERISTICS

1

NAME OF THE MEDICINAL PRODUCT
Max Remedies Throat Lozenges

2

QUALITATIVE AND QUANTITATIVE COMPOSITION
Cetylpyridinium Chloride BP 1.4mg

3

PHARMACEUTICAL FORM
Compressed Lozenge

4

CLINICAL PARTICULARS

4.1

Therapeutic indications
For the symptomatic relief of non-inflammatory sore throat and the congestion
caused by colds and nasal catarrh.

4.2

Posology and method of administration
Adults, elderly and children over 12 years: Suck one lozenge every four hours
as required.
Oral administration.

4.3

Contraindications
None known.

4.4

Special warnings and precautions for use
Keep out of reach of children. If symptoms persist consult your doctor.

4.5

Interaction with other medicinal products and other forms of interaction
None reported.

4.6

Pregnancy and lactation
No animal or human data to prove it is unsafe.

4.7

Effects on ability to drive and use machines
None.

4.8

Undesirable effects
Skin rash

4.9

Overdose
Symptoms: Nausea, vomiting, gastric irritation and collapse.
Emergency procedures: gastric lavage and appropriate symptomatic supportive
measures.

5

PHARMACOLOGICAL PROPERTIES

5.1

Pharmacodynamic properties

Cetylpyridinium Chloride is a cationic disinfectant with bactericidal
properties.

5.2

Pharmacokinetic properties
Not applicable.

5.3

Preclinical safety data
None.

6

PHARMACEUTICAL PARTICULARS

6.1

List of excipients
Menthol
Methyl Salicylate
Citric Acid
Eucalyptus Oil
Sucrose
Sorbitol
Magnesium Stearate

6.2

Incompatibilities
None Known.

6.3

Shelf life
3 years

6.4

Special precautions for storage

None.

6.5

Nature and contents of container
Packs of 20 and 35 tablets in white polypropylene tubes with HD polythene
caps.

6.6

Special precautions for disposal
No special requirements.

7

MARKETING AUTHORISATION HOLDER
Max Remedies Limited
Stoney Gate House
2 Greenfield Road
Holmfirth
West Yorkshire
HD9 2JT

8

MARKETING AUTHORISATION NUMBER(S)
PL 31308/0026

9

DATE OF FIRST AUTHORISATION/RENEWAL OF THE
AUTHORISATION
26 February 1990

10

DATE OF REVISION OF THE TEXT
20th July 2009

Expand view ⇕

Source: Medicines and Healthcare Products Regulatory Agency

Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective or appropriate for any given patient. If you have questions about the substances you are taking, check with your doctor, nurse or pharmacist.

Hide